# Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH

> **NCT02094001** · PHASE2 · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 6 (actual)

## Conditions studied

- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **RADIATION:** Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)

## Key facts

- **NCT ID:** NCT02094001
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094001, "Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02094001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*